Immune microenvironment of prostate cancer (PCa) is implicated in disease progression.
However, previous studies have not fully explored PCa immune microenvironment. This …

Background Prostate cancer (PCa) is one of the most common cancers and the fifth leading
cause of cancer-related death in men. Immune responses in the tumor microenvironment …

Background The tumor microenvironment (TME) primarily comprises cancer cells, cancer-
infiltrating immune cells, and stromal cells. The tumor cells alter the TME by secreting …

Background Prostate cancer (PCa) is an immune-responsive disease. The current study
sought to explore a robust immune-related prognostic gene signature for PCa. Methods …

Androgen deprivation therapy (ADT) is a cornerstone treatment for locally advanced or
metastatic prostate cancer (PCa). However, its potential effects on the tumor immune …

Background This study was to explore the infiltration pattern of immune cells in the prostate
cancer (PCa) microenvironment and evaluate the possibility of specific infiltrating immune …

Background The tumor microenvironment (TME) has recently been proven to play a crucial
role in the development and prognosis of tumors. However, the current knowledge on the …

Background There is significant heterogeneity in prostate cancer (PCa), but immune status
can reflect its prognosis. This study aimed to explore immune-related gene-based novel …

Background: Immunotherapy has a significant effect on the treatment of many tumor types.
However, prostate cancers generally fail to show significant responses to immunotherapy …

Prostate cancer (PCa) is one of the most common malignancies in male. We aim to establish
a novel gene signature for immune infiltration and outcome (biochemical recurrence (BCR) …